Skip to content Skip to navigation

Improving safety of human pluripotent stem cell therapies

Safety is a key consideration of any cell therapy, as transplanted cells may form tumors or mis-differentiate in vivo. With Matt Porteus's lab, we developed kill-switch systems to kill undifferentiated human pluripotent stem cells (with or without their differentiated progeny) with specific drugs.